This Growth Stock Surged 63% in 2024. Here's Why 2025 Could Bring An Even Bigger Gain.Eli Lilly stock has gained 63% in 2024, primarily due to the success of its Mounjaro weight-loss drug.
We know so little about taking weight-loss drugs without prescription is it really worth it? | Devi SridharThe popularity of GLP-1 drugs for weight loss is rising sharply, but concerns around safety and effectiveness remain largely unaddressed.
Eilis O'Hanlon on The Skinny Jab Revolution: There was one mention to the food environment being "toxic" - but no exploration at all of ultra-processed foodsOzempic and similar GLP-1 drugs have rapidly transformed weight loss efforts, prioritizing convenience over lifestyle changes.
Eli Lilly's weight-loss drug may prevent diabetes - but there's 1 unanswered questionGLP-1 drugs Zepbound and Mounjaro significantly reduce diabetes risk by 94% while aiding substantial weight loss in pre-diabetic adults.
Oprah Winfrey reveals taking GLP-1 weight-loss drug made her realize what she got wrong about 'thin people'Oprah Winfrey's perspective on weight and hunger changed after using GLP-1 drugs, challenging misconceptions about thin people and willpower.
1 in 4 companies say they are considering covering weight-loss drug costsEmployers are cautiously considering covering anti-obesity medications despite significant cost concerns and varying interest based on company size.
This Growth Stock Surged 63% in 2024. Here's Why 2025 Could Bring An Even Bigger Gain.Eli Lilly stock has gained 63% in 2024, primarily due to the success of its Mounjaro weight-loss drug.
We know so little about taking weight-loss drugs without prescription is it really worth it? | Devi SridharThe popularity of GLP-1 drugs for weight loss is rising sharply, but concerns around safety and effectiveness remain largely unaddressed.
Eilis O'Hanlon on The Skinny Jab Revolution: There was one mention to the food environment being "toxic" - but no exploration at all of ultra-processed foodsOzempic and similar GLP-1 drugs have rapidly transformed weight loss efforts, prioritizing convenience over lifestyle changes.
Eli Lilly's weight-loss drug may prevent diabetes - but there's 1 unanswered questionGLP-1 drugs Zepbound and Mounjaro significantly reduce diabetes risk by 94% while aiding substantial weight loss in pre-diabetic adults.
Oprah Winfrey reveals taking GLP-1 weight-loss drug made her realize what she got wrong about 'thin people'Oprah Winfrey's perspective on weight and hunger changed after using GLP-1 drugs, challenging misconceptions about thin people and willpower.
1 in 4 companies say they are considering covering weight-loss drug costsEmployers are cautiously considering covering anti-obesity medications despite significant cost concerns and varying interest based on company size.
The weight loss drug revolution is shrinking America's waistlineGLP-1 drugs are potentially reversing America's obesity crisis with projected usage rising to 18 million by 2029.
An Unexpected Irony of Popular Weight-Loss TherapyGLP-1 weight-loss drugs may pose risks to vision, highlighting an ironic medical paradox.
The weight loss drug revolution is shrinking America's waistlineGLP-1 drugs are potentially reversing America's obesity crisis with projected usage rising to 18 million by 2029.
An Unexpected Irony of Popular Weight-Loss TherapyGLP-1 weight-loss drugs may pose risks to vision, highlighting an ironic medical paradox.
Scientists Who Pioneered GLP-1 Drugs Honored With AwardLasker Awards highlight significant contributions to medical research, recognizing advances in obesity treatment through GLP-1-based drugs.
Ars Live: What else can GLP-1 drugs do? Join us Tuesday for a discussion.GLP-1 drugs have significant roles beyond diabetes and obesity treatment, engaging multiple body systems and presenting new avenues for chronic condition research.
Relative of Ozempic Failed to Treat Parkinson's Disease in TrialRecent study shows GLP-1 drugs aren't effective for treating or slowing progression of Parkinson's disease.
Scientists Who Pioneered GLP-1 Drugs Honored With AwardLasker Awards highlight significant contributions to medical research, recognizing advances in obesity treatment through GLP-1-based drugs.
Ars Live: What else can GLP-1 drugs do? Join us Tuesday for a discussion.GLP-1 drugs have significant roles beyond diabetes and obesity treatment, engaging multiple body systems and presenting new avenues for chronic condition research.
Relative of Ozempic Failed to Treat Parkinson's Disease in TrialRecent study shows GLP-1 drugs aren't effective for treating or slowing progression of Parkinson's disease.
GLP-1 drugs like Ozempic may have health benefits, but they come with risksGLP-1 drugs have been found to lower risks for various health conditions, but they also present significant side effects.
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risksGLP-1 drugs like Ozempic show promise for weight management and various health benefits but also have significant risks.
GLP-1 drugs like Ozempic may have health benefits, but they come with risksGLP-1 drugs have been found to lower risks for various health conditions, but they also present significant side effects.
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risksGLP-1 drugs like Ozempic show promise for weight management and various health benefits but also have significant risks.
What's the Secret behind Ozempic's Sweeping Health Benefits?GLP-1 drugs like Ozempic have broader medical applications beyond diabetes and weight loss, showing promise in treating kidney, cardiovascular, liver diseases, and neurological disorders.
A New Study Explored the Pros and Cons of Drugs Like OzempicGLP-1 drugs like Ozempic and Wegovy show promise in treating various health conditions beyond diabetes, but also carry risks for some chronic issues.
What's the Secret behind Ozempic's Sweeping Health Benefits?GLP-1 drugs like Ozempic have broader medical applications beyond diabetes and weight loss, showing promise in treating kidney, cardiovascular, liver diseases, and neurological disorders.
A New Study Explored the Pros and Cons of Drugs Like OzempicGLP-1 drugs like Ozempic and Wegovy show promise in treating various health conditions beyond diabetes, but also carry risks for some chronic issues.
Cheaper Versions of Popular New Weight-Loss Drugs Are Being DevelopedChinese and Indian pharmaceutical companies are developing cheaper weight-loss drug versions to reach more people globally.
Maker of weight-loss drugs to ask Trump to pause price negotiations: ReportBiden administration proposed allowing Medicare to cover anti-obesity medications to improve long-term health and reduce future costs.CBO predicts Medicare's anti-obesity drug coverage would lead to significant net costs for taxpayers.
Weight loss market: Eli Lilly and Novo Nordisk's rivals muscle inSmaller competitors are preparing to enter the weight-loss drug market dominated by Eli Lilly and Novo Nordisk.
Cheaper Versions of Popular New Weight-Loss Drugs Are Being DevelopedChinese and Indian pharmaceutical companies are developing cheaper weight-loss drug versions to reach more people globally.
Maker of weight-loss drugs to ask Trump to pause price negotiations: ReportBiden administration proposed allowing Medicare to cover anti-obesity medications to improve long-term health and reduce future costs.CBO predicts Medicare's anti-obesity drug coverage would lead to significant net costs for taxpayers.
Weight loss market: Eli Lilly and Novo Nordisk's rivals muscle inSmaller competitors are preparing to enter the weight-loss drug market dominated by Eli Lilly and Novo Nordisk.
Why do obesity drugs seem to treat so many other ailments?GLP-1 drugs may reduce cravings for alcohol and other addictions while also addressing obesity and other health conditions.
Opinion | Pfizer Stopped Us From Getting Ozempic Decades AgoGLP-1 drugs have the potential to significantly impact obesity and multiple chronic diseases, shaping healthcare for years to come.
Why do obesity drugs seem to treat so many other ailments?GLP-1 drugs may reduce cravings for alcohol and other addictions while also addressing obesity and other health conditions.
Opinion | Pfizer Stopped Us From Getting Ozempic Decades AgoGLP-1 drugs have the potential to significantly impact obesity and multiple chronic diseases, shaping healthcare for years to come.
Why Is There So Much Off-Brand Oral Ozempic for Sale Online?Oral compounded versions of GLP-1 drugs are gaining popularity despite lacking evidence of efficacy.The rise of these medications follows injectable versions facing shortages.Compounded drugs are often cheaper and more convenient, appealing to patients afraid of needles.
Weight loss care is leading IPO-hopeful Omada Health's latest growth surge as Ozempic boom continuesOmada Health's weight loss program is driving its growth and public market ambitions, with a notable shift towards GLP-1 care.
More Than 900 Patients Say Ozempic and Similar Drugs Unexpectedly Injured ThemOver 900 individuals are suing drugmakers, claiming GLP-1 drugs like Ozempic caused severe gastrointestinal injuries, even after stopping usage.
2 Weight Loss Drug Stocks Worth Stashing Away for YearsHigh-growth sectors, including GLP-1 drugs and AI, face potential corrections despite long-term growth expectations.Top stocks may be overpriced, leading to painful corrections as market recalibrates valuations.
Weight-loss drug boom sparks battle over pharmacy copycatsThe surge in compounded GLP-1 drugs addresses availability but leads to regulatory issues and legal battles.Compounding offers personalized medication options, even amidst drug shortages.
Researchers Say There's Something Fishy With All These Studies Showing Huge Health Benefits From Ozempic-Like DrugsThe recent commentary highlights conflicts of interest surrounding GLP-1 weight loss drugs and the need for unbiased research funding.
Workplace insurance could soon be stripped downRising demand for GLP-1 drugs is driving up workplace insurance costs, leading to predictions of reduced employee benefits.
Ozempic and Wegovy should be covered by Medicare as weight loss treatments: KFF pollGLP-1 drugs used for diabetes and heart disease gaining popularity as weight loss treatments.KFF survey shows limited usage of GLP-1 drugs for weight loss, with interest in Medicare coverage for weight loss drugs.
Hims & Hers says it's selling a GLP-1 weight loss drug for 85% less than Wegovy. Here's the price.Hims & Hers Health offers GLP-1 weight loss drugs at a fraction of the cost of brand-name competitors, leading to a significant increase in shares.
Hims & Hers Health stock price nears record high on news that it will offer GLP-1 weight-loss drugs amid shortagesHims & Hers Health announced the addition of GLP-1 injectable drugs to its offerings at significantly reduced prices, leading to a surge in stock prices.
Hims & Hers says it's selling a GLP-1 weight loss drug for 85% less than Wegovy. Here's the price.Hims & Hers Health offers GLP-1 weight loss drugs at a fraction of the cost of brand-name competitors, leading to a significant increase in shares.
Hims & Hers Health stock price nears record high on news that it will offer GLP-1 weight-loss drugs amid shortagesHims & Hers Health announced the addition of GLP-1 injectable drugs to its offerings at significantly reduced prices, leading to a surge in stock prices.
10 Facts About GLP-1 Weight Loss Medications Your Doctor Might Not MentionNeedle phobia can impact GLP-1 therapy, while managing feeling of fullness is crucial for successful treatment.
Taking Ozempic or other weight-loss meds? Watch your diet to avoid exchanging one problem for another'GLP-1 drugs like Wegovy are helping with weight loss by changing eating habits and increasing satiation.
Daily briefing: How obesity drugs like Ozempic create a full feelingIdentified brain area in hypothalamus responsible for fullness in GLP-1 drug users